ER-Β mediates 17Β-estradiol attenuation of HIV-1 Tat-induced apoptotic signaling

Synapse

Volumn 64, Issue 11, 2010, Pages 829-838

  Adams, Sheila M ^a   Aksenova, Marina V ^a   Aksenov, Michael Y ^a   Mactutus, Charles F ^a   Booze, Rosemarie M ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

AIDS; Cell death; Estrogen; Neuroprotection

Indexed keywords

CASPASE 3; CASPASE 9; ESTRADIOL; ESTROGEN RECEPTOR BETA; FULVESTRANT; PROTEIN BAX; PROTEIN BCL 2; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; HUMAN IMMUNODEFICIENCY VIRUS 1; MITOCHONDRION; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASES; CELL SURVIVAL; CEREBRAL CORTEX; DRUG INTERACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR BETA; ESTROGENS; NEURONS; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 78149473179     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20793     Document Type: Article

References (67)

1. Aksenov MY, Hasselrot U, Bansal Ak, Wu G, Nath A, Anderson C, Mactutus CF, Booze RM. 2001. Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum. Neurosci Lett 305: 5-8.
2. Aksenov MY, Hasselrot U, Wu G, Nath A, Anderson C, Mactutus CF, Booze RM. 2003. Temporal relationships between HIV-1 Tat-induced neuronal degeneration. OX-42 immunoreactivity, reactive astrocytosis, and protein oxidation in the rat striatum. Brain Res 987: 1-9.
3. Aksenova MV, Aksenov MY, Adams SM, Mactutus CF, Booze RM. 2009. Neuronal survival and resistance to HIV-1 Tat toxicity in the primary culture of rat fetal neurons. Exp Neurol 5: 253-263.
4. Amantea D, Russo R, Bagetta G, Corasaniti MT. 2005. From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens. Pharmacol Res 52: 119-132.
5. Ances BM, Ellis RJ. 2007. Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol 27: 86-92.
6. Arnold S, Beyer C. 2009. Neuroprotection by estrogen in the brain: The mitochondrial compartment as presumed therapeutic target. J Neurochem 110: 1-11.
7. Bonavia R, Bajetto A, Barbero S, Albini A, Noonan DM, Schettini G. 2001. HIV-1 tat causes apoptotic death and calcium homeostasis alterations in rat neurons. Biochem Biophys Res Commun 288: 301-308.
8. Bruce-Keller AJ, Chauhan A, Dimayuga FO, Gee J, Keller JN, Nath A. 2003. Synaptic transport of human immunodeficiency virus-tat protein causes neurotoxicity and gliosis in rat brain. J Neurosci 23: 8417-8422.
9. Danial NN, Korsmeyer SJ. 2004. Cell death: Critical control points. Cell 116: 205-219.
10. Ellis RJ, Deutsch R, Heaton RK, Marcotte TD, McCutchan JA, Nelson JA, Abramson I, Thal LJ, Atkinson JH, Wallace MR, Grant I. 1997. Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Arch Neurol 54: 416-424.
11. Estratova AA, Mironova EV, Dvoretskova EA, Antonov SM. 2009. Apoptosis and the receptor specificity of its mechanisms during the neurotoxic action of glutamate. Neurosci Behav Physiol 39: 353-362.
12. Eugenin EA, King JE, Nath A, Calderon TM, Zukin RS, Bennett MV, Berman JW. 2007. HIV-tat induces formation of an LRP-PSD-95-NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes. Proc Natl Acad Sci USA 104: 3438-3443.
13. Everall IP, Luthert PJ, Lantos PL. 1991. Neuronal loss in the frontal cortex in HIV infection. Lancet 337: 1119-1121.
14. Everall IP, Luthert PJ, Lantos PL. 1993. Neuronal number and volume alterations in the neocortex of HIV infected individuals. J Neurol Neurosurg Psychiatry 56: 481-186.
15. Farzadegan JH, Hoover DR, Astemborski J, Lyles CM, Margolick JB, Markham RB, Quinn TC, Vlahov D. 1998. Sex differences in HIV-1 viral load and progression to AIDS. Lancet 352: 1510-1514.
16. Fischer CP, Gundersen HJG, Pakkenberg B. 1999. Preferential loss of large neocortical neurons during HIV infection: A study of the size distribution of neocortical neurons in the human brain. Brain Res 828: 119-126.
17. Gandhi M, Bacchetti P, Miotti P, Quinn TC, Veronese F, Greenblatt RM. 2002. Does patient sex affect human immunodeficiency virus levels? Clin Infect Dis 35: 313-322.
18. Garden GA, Budd SL, Tsai E, Hanson L, Kaul M, D'Emilia DM, Friedlander RM, Yuan J, Masliah E, Lipton SA. 2002. Caspase cascades in human immunodeficiency virus-associated neurodegeneration. J Neurosci 22: 4015-4024.
19. Gilad J, Walfisch A, Borer A, Schlaeffer F. 2003. Gender difference and sex-specific manifestations associated with human immunodeficiency virus infection in women. Eur J Obstet Gynecol Reprod Biol 109: 199-205.
20. Green D, Kroemer G. 1998. The central executioners of apoptosis: Caspases or mitochondria? Trends Cell Biol 8: 267-271.
21. Green DR, Kroemer G. 2004. The pathophysiology of mitochondria cell death. Science 305: 626-629.
22. Green PS, Simpkins JW. 2000. Neuroprotective effects of estrogens: potential mechanisms of action. Int J Dev Neurosci 18: 347-358.
23. Haeberlein SL. 2004. Mitochondrial function I apoptotic neuronal cell death. Neurochem Res. 29: 521-530.
24. Haughey NJ, Nath A, Mattson MP, Slevin JT, Geiger JD. 2001. HIV-1 tat through phosphorylation of NMDA receptors potentiates glutamate excitoxicity. J Neurochem 78: 457-467.
25. Hudson L, Liu J, Nath A, Jones M, Raghavan R, Narayan O, Male D, Everall I. 2000. Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J Neurovirol 6: 145-155.
26. Honda K, Sawada H, Kihara T, Urushitani M, Nakamizo T, Akaike A, Shimohama S. 2000. Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons. J Neurosci Res 60: 321-327.
27. Honda K, Shimohama S, Sawada H, Kihara T, Nakamizo T, Shibasaki H, Akaike A. 2001. Nongenomic antiapoptotic signal transduction by estrogen in cultured cortical neurons. J Neurosci Res 64: 466-475.
28. Hosoda T, Nakajima H, Honjo H. 2001. Estrogen protects neuronal cells from amyloid beta-induced apoptotic cell death. Neuroreport 12: 1965-1970.
29. Jones G, Power C. 2006. Regulation of neural cell survival by HIV-1 infection. Neurobiol Dis 21: 1-17.
30. Kendall SL, Anderson CF, Turchan-Cholewo J, Land CL, Mactutus CF, Booze RM. 2005. Gonadal steroids differentially modulate neurotoxicity of HIV and cocaine: Testosterone and ICI 182, 780 sensitive mechanism. BMC Neurosci 6: 40.
31. Kim HJ, Martemyanov KA, Thayer SA. 2008. Human immunodeficiency virus protein Tat induces synapses loss via a reversible process that is distinct from cell death. J Neurosci 28: 12604-12613.
32. King JE, Eugenin EA, Buckner CM, Berman JW. 2006. HIV tat and neurotoxicity. Microbes Infect 8: 1347-1357.
33. Klinge CM. 2008. Estrogenic control of mitochondrial function and biogenesis. J Cell Biochem 105: 1342-1351.
34. Kroemer G, Galluzi L, Brenner C. 2007. Mitochondrial membrane permeabilization in cell death. Physiol Rev 87: 99-163.
35. Kruman II, Nath A, Mattson MP. 1998. HIV-1 protein tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp Neurol 154: 276-288.
36. McArthur JC, Brew BJ, Nath A. 2005. Neurological complications of HIV infection. Lancet Neurol 4: 543-555.
37. Miller NR, Jover T, Cohen HW, Zukin RS, Etgen AM. 2005. Estrogen can act via estrogen receptor alpha and beta to protect hippocampal neurons against global ischemia-induced cell death. Endocrinology 146: 3070-3079.
38. Moore DJ, Masliah E, Rippeh JD, Gonzalez R, Carey CL, Cherner M, Ellis RJ, Achim CL, Marcotte TD, Heaton RK, Grant I;HNRC Group. 2006. Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS 20: 879-887.
39. Morissette M, Le Saux M, D'Astous M, Jourdain S, Al Sweidi S, Morin N, Estrada-Camarena E, Mendez P, Garcia-Segura LM, Di Paolo T. 2008. Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain. J Steroid Biochem Mol Biol 108: 327-338.
40. Myhre AJ, Dorsa DM. 2006. Estrogen activates rapid signaling in the brain: Role of estrogen receptor alpha and estrogen receptor beta in neurons and glia. Neuroscience 138: 851-858.
41. Namura S, Zhu J, Fink K, Endres M, Srinivasan A, Tomaselli KJ, Yuan J, Moskowitz MA. 1998. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J Neurosci 18: 3659-3668.
42. New DR, Ma M, Epstein LG, Nath A, Gelbard HA. 1997. Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. J Neurovirol 3: 168-173.
43. Nilsen J. 2008. Estradiol and neurodegenerative oxidative stress. Front Neuroendocrinol 29: 463-475.
44. Nilsen J, Chen S, Irwin RW, Iwamoto S, Brinton RD. 2006. Estrogen protects neuronal cells from amyloid Β-induced apoptosis via regulation of mitochondrial proteins and function. BMC Neurosci 7: 74.
45. Paul R, Cohen R, Navia B, Tashima K. 2002. Relationships between cognition and structural neuroimaging finding in adults with human immunodeficiency virus type-1. Neurosci Biobehav Rev 26: 353-359.
46. Perez A, Probert AW, Wang KK, Sharmeen L. 2001. Evaluation of HIV-1 tat induced neurotoxicity in rat cortical cell culture. J Neurovirol 7: 1-10.
47. Pike CJ, Carroll JC, Rosario ER, Barron AM. 2009. Protective actions of sex steroids hormones in Alzheimer's disease. Front Neuroendocrinol 30: 239-258.
48. Rezza G, Lepri AC, d'Arminio-Monforte A, Pezzotie P, Castelli F, Dianzani F, Lazzarin A, De Luca A, Arlotti M, Leoncini F, Manconi PE, Rizzardini G, Minoli L, Poggio A, Ippolito G, Phillips AN, Moroni M. 2000. Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection. ICONA Study Group. J Acquir Immune Defic Syndr 25: 56-62.
49. Sevigny JJ, Albert SM, McDermott MP, Schiffitto G, McArthur JC, Sacktor N, Conant K, Seines OA, Stern Y, McClernon DR, Palumbo D, Kieburtz K, Riggs G, Cohen B, Marder K, Epstein LG. 2007. An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Arch Neurol 64: 97-102.
50. Simpkins JW, Dykens JA. 2008. Mitochondrial mechanisms of estrogen neuroprotection. Brain Res Rev 57: 421-430.
51. Singh M. 2001. Ovarian hormones elicit phosphorylation of Akt and extracellular signal regulated kinase in explants of the cerebral cortex. Endocrine 14: 407-415.
52. Stennicke HR, Salvesen GS. 2000. Caspases-controlling intracellular signals by protease zymogen activation. Biochim Biophys Acta 1477: 299-306.
53. Sterling TA, Vlahov D, Astermborski J, Hoover DR, Margolick JB, Quinn TC. 2001. Initial plasma HIV-RNA levels and progression to AIDS I women and men. N Engl J Med 344: 720-725.
54. Stout JC, Ellis RJ, Jernigan TL, Archibald SL, Abramson I, Wolfson T, McCutchan JA, Wallace MR, Atkinson JH, Grant I. 1998. Progressive cerebral volume loss in human immunodeficiency virus infection: A longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group. Arch Neurol 55: 161-168.
55. Su JH, Nichol KE, Sitch T, Sheu P, Chubb C, Miller BL, Tomaselli KJ, Kim RC, Cotman CW. 2000. DNA damage and activated caspase-3 expression I neurons and astrocytes: Evidence for apoptosis in frontotemporal dementia. Exp Neurol 163: 9-19.
56. Turchan J, Anderson C, Hauser KF, Sun Q, Zhang J, Liu Y, Wise PM, Kruman I, Maragos W, Mattson MP, Booze R, Nath A. 2001. Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine. BMC Neurosci 2: 3.
57. Umeh OC, Currier JS. 2006. Sex differences in pharmacokinetics and toxicity of antiretroviral therapy. Expert Opin Drug Metab Toxicol 2: 273-283.
58. van de Bovenkamp M, Nottet HS, Pereira CF. 2002. Interactions of human immunodeficiency virus-1 proteins with neurons: Possible role in the development of human immunodeficiency virus-1- associated dementia. Eur J Clin Invest 32: 619-627.
59. Vanoye-Carlo A, Mendoza-Rodriguez CA, Morales T, Langley E, Cerbon M. 2009. Estrogen receptors increased expression during hippocampal neuroprotection in lactating rats. J Steroid Biochem Mol Biol 116: 1-7.
60. Wallace DR. 2006. HIV Neurotoxicity: Potential therapeutic interventions. J Biomed Biotechnol 2006: 1-10.
61. Wallace DR, Dodson S, Nath A, Booze RM. 2006. Estrogen attenuates gp120 and tat(1-72)-induced oxidative stress and prevents loss of dopamine transporter function. Synapse 59: 51-60.
62. Weis S, Haug H, Budka H. 1993. Neuronal damage in the cerebral cortex of AIDS brains: A morphometric study. Acta Neuropathol (Berl.) 85: 185-189.
63. Wiley CA, Baldwin M, Achim CL. 1996. Expression of HIV regulatory and structural mRNA in the central nervous system. AIDS 10: 843-847.
64. Wilson ME, Dimayuga FO, Reed JL, Curry TE, Anderson CF, Nath A, Bruce-Keller AJ. 2006. Immune modulation by estrogens: Role in CNS HIV-1 infection. Endocrine 29: 289-297.
65. Yang SH, Liu R, Perez EJ, Wen Y, Stevens SM, Valencia T, Brun-Zinkernage AM, Prokai L, Will Y, Dykens J, Koulen P, Simpkins JW. 2004. Mitochondrial localization of estrogen receptor beta. Proc Natl Acad Sci USA 101: 4130-4135.
66. Zhang Y, Goodyer C, LeBlanc A. 2000. Selective and protracted apoptosis in human primary neurons microinjected with active caspase -3, -6, -7, and -8. J Neurosci 20: 8384-8389.
67. Zheng J, Thylin MR, Ghorpade A, Xiong H, Persidsky Y, Cotter R, Niemann D, Che M, Zeng YC, Gelbard HA, Shepard RB, Swartz JM, Gendelman HE. 1999. Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1 associated dementia. J Neuroimmunol 98: 185-200.